Policy Notices

• AHRQ Announcement of Childcare Costs Allowance for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows (F32s)
  (NOT-HS-22-013)
  Agency for Healthcare Research and Quality
  

• AHRQ Announcement of Childcare Costs Allowance for Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Awards (T32) Beginning in FY2022
  (NOT-HS-22-014)
  Agency for Healthcare Research and Quality
  

• Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: January 2023 Councils
  (NOT-OD-22-113)
  National Institutes of Health
  

• NIH Response to Registration Issues in SAM.gov
  (NOT-OD-22-119)
  National Institutes of Health
  

General Notices

• Notice of Pre-Application Technical Assistance Webinar for RFA-OD-22-011, "Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed)"
  (NOT-MD-22-018)
  National Institute on Minority Health and Health Disparities
  

• Inviting Comments and Suggestions on the Development of a Prize Competition for Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility.
  (NOT-OD-22-109)
  National Institutes of Health
  

• Request for Information (RFI): Challenges and Opportunities in Health and Science Communication Research
  (NOT-RM-22-012)
  Office of Strategic Coordination (Common Fund)
  

• Request for Information (RFI): Inviting Comments and Suggestions on the Potential Development of a Challenge Prize for Transformative Genome Editor Delivery Technologies
  (NOT-RM-22-013)
  Office of Strategic Coordination (Common Fund)
  

Notice of Changes to Funding Opportunities

• Notice of Change to Award Budget and Funding Opportunity Description in RFA-CA-22-015 "Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)"
  (NOT-CA-22-084)
  National Cancer Institute
  

• Notice to Extend the 2022 Application Due Date for PAR-21-178 - "Drug Development Tools Research Grants (U01) Clinical Trial Optional"
  (NOT-FD-22-011)
  Food and Drug Administration
  

• Notice of Correction to Foreign Components for PAR-21-056: Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
  (NOT-NS-22-069)
  National Institute of Neurological Disorders and Stroke
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C Clinical Trial Not Allowed).
  (NOT-DK-22-020)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

Notices of Special Interest

• Notice of Special Interest: Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAA
  (NOT-AA-22-012)
  National Institute on Alcohol Abuse and Alcoholism
  

• Notice of Special Interest (NOSI): Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP)
  (NOT-AI-22-042)
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI): Towards Developing a Cure for HBV in HIV/HBV Co-Infection
  (NOT-AI-22-043)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Special Interest (NOSI): Administrative Supplements for Lyme Disease and other Tickborne Illnesses
  (NOT-AI-22-048)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics
  (NOT-CA-22-083)
  National Cancer Institute
  

• Notice of Special Interest: Achieving Tissue Robustness Through Harnessing Immune System Plasticity
  (NOT-DE-22-005)
  National Institute of Dental and Craniofacial Research
  

Funding Opportunities

• Education Program on Translational Devices (R25 Clinical Trial Not Allowed)
  (PAR-22-146)
  National Institute of Neurological Disorders and Stroke
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): July 29, 2022
  
  

• Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
  (RFA-AG-23-031)
  National Institute on Aging
  Application Receipt Date(s): October 17, 2022
  
  

• NIAMS Rheumatic Diseases Research Resource-based Centers (P30 - Clinical Trial Not Allowed)
  (RFA-AR-23-002)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): September 13, 2022
  
  

• Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional)
  (RFA-DA-23-012)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 11, 2023
  
  

• Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)
  (RFA-DA-23-040)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 10, 2022
  
  

• SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
  (RFA-ES-22-004)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): July 29, 2022
  
  

• Understanding the role of Gut Immune dysfunction and Gut Microbiome in pathogenesis of Central Nervous System co-morbidities in people living with HIV (R21 Clinical Trial Not Allowed)
  (RFA-MH-22-230)
  National Institute of Mental Health
  Application Receipt Date(s): Not Applicable
  
  

• NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
  (RFA-RM-22-021)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 02, 2022